<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Study shows immune-modulators can reduce severity of equine respiratory disease </title><link>/b/veterinary-news/posts/90307</link><description> Zoetis, maker of Zylexis, is highlighting a new review published in Veterinary Immunology and Immunopathology , which has concluded that immune-modulators may provide a
valuable contribution to the reduction of some equine respiratory diseases 
 The</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>